Anti-CD25 therapy impairs donor-specific Th1 and Th2 cytokine-producing peripheral blood cells after clinical heart transplantation.

van Besouw, N M

Anti-CD25 therapy impairs donor-specific Th1 and Th2 cytokine-producing peripheral blood cells after clinical heart transplantation. [electronic resource] - Transplantation proceedings Nov 2002 - 2942-3 p. digital

Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't

0041-1345

10.1016/s0041-1345(02)03498-x doi


Antibodies, Monoclonal--therapeutic use
Antibodies, Monoclonal, Humanized
Cytokines--antagonists & inhibitors
Daclizumab
Dose-Response Relationship, Drug
Heart Transplantation--immunology
Humans
Immunoglobulin G--therapeutic use
Immunosuppressive Agents--therapeutic use
Interferon-gamma--blood
Lymphocyte Transfusion
Placebos
Receptors, Interleukin-2--immunology
Th1 Cells--drug effects
Th2 Cells--drug effects